Insider Sale: Director James Young Sells Shares of Novavax Inc (NVAX)

By Yahoo! Finance | Jun 25, 2024 at 07:17 PM EST

Novavax Inc is a biotech firm specializing in vaccines for infectious diseases. Recent insider selling by James Young, totaling 15,000 shares, reflects a trend of insider selling and no buying. The stock is considered undervalued with a price-to-GF-Value ratio of 0.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.